TORONTO, Ontario, May 2, 2007 - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that Mr. Joseph Zakrzewski has been appointed to the Company’s Board of Directors.
